Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1690-1696

  Herrstedt, J ^a   Sigsgaard, T ^a   Handberg, J ^a   Schousboe, B M B ^a   Hansen, M ^a   Dombernowsky, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; METOPIMAZINE; ONDANSETRON; PLACEBO; TENIPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT PLANNING; VOMITING;

EID: 0030948336     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1690     Document Type: Article

References (28)

1. Gralla RJ, Tyson LB, Kris MG, et al: Management of chemotherapy-induced nausea and vomiting. Med Clin North Am 71:289-301, 1987
2. Gralla RJ, Itri LM, Pisko SE: Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305:905-909, 1981
3. 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 322:816-821, 1990
4. De Mulder PHM, Seynaeve C, Vermorken JB, et al: Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: A multicenter, randomized, double-blind, crossover study. Ann Intern Med 113:834-840, 1990
5. Hainsworth J, Harvey W, Pendergrass K, et al: A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 9:721-728, 1991
6. Roila F, Tonato M, Cognetti F, et al: Prevention of cisplatin-induced emesis: A double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 9:675-678, 1991
7. Smith DB, Newlands ES, Rustin GJS, et al: Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338:487-490, 1991
8. Smyth JF, Coleman RE, Nicolson M, et al: Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ 303:1423-1426, 1991
9. Hesketh PJ, Harvey WH, Harker WG, et al: A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 12:506-600, 1994
10. Moertel CG, Reitemeier RJ: Controlled studies of metopimazine for the treatment of nausea and vomiting. J Clin Pharmacol 13:283-287, 1973
11. Israel L, Rodary C: Treatment of nausea and vomiting related to anticancerous multiple combination chemotherapy: Results of two controlled studies. J Intern Med Res 6:235-240, 1978
12. R) i et åbent og et dobbel-blindt forsøg. Ugeskr Laeger 138:1769-1770, 1976
13. Herrstedt J, Sigsgaard T, Boesgaard M, et al: Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 328:1076-1080, 1993
14. Bateman DN, Rawlins MD, Simpson JM: Extrapyramidal reactions with metoclopramide. BMJ 291:930-932, 1985
15. Fozard JR, Mobarok Ali ATM: Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol 49:109-112, 1978
16. 1-adrenergic receptors. Cancer Chemother Pharmacol 33:53-56, 1993
17. Herrstedt J, Jørgensen M, Angelo HR: The effect of food on serum concentrations of metopimazine. Br J Clin Pharmac 30:237-243, 1990
18. Lachin JM: Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 2:93-113, 1981
19. Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmac 8:7-20, 1979
20. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, NY, McGraw-Hill, 1956
21. Tonato M, Roila F, del Favero A: Methodology of antiemetic trials. A review. Ann Oncol 2:107-114, 1991
22. Kris MG, Pisters KMW, Hinkley L: Delayed emesis following anticancer chemotherapy. Support Care Cancer 2:297-300, 1994
23. Navari RM, Madajewicz S, Anderson N, et al: Oral ondansetron for the control of cisplatin-induced delayed emesis: A large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. J Clin Oncol 13:2408-2416, 1995
24. Italian Group for Antiemetic Research: Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Lancet 340:96-99, 1992
25. Kris MG, Gralla RJ, Tyson LB, et al: Controlling delayed vomiting: Double-blind, randomized, trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7:108-114, 1989
26. Italian Group for Antiemetic Research: Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cycles. Ann Oncol 5:585-589, 1994
27. Fredrikson M, Hursti TJ, Steineck G, et al: Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer 70:642-645, 1994
28. Heron JF, Goedhals L, Jordaan JP, et al: On behalf of the Granisetron Study Group. Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. Ann Oncol 5:579-585, 1994